Genomadix Inc.
PrivateLast Round
Strategic
Aug 29, 2022
Total Funding Raised
$5.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomadix Inc. operates in Healthcare & Life Sciences and is based in Kanata. Its latest recorded funding round was a Strategic round in August 2022.
Genomadix Inc. is a medical diagnostics company developing a portable, real-time PCR platform designed for point-of-need genetic testing in areas like precision medicine and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomadix Inc. Comparables
Compare Genomadix Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| genedrive plc | 84% | |
| Rover Diagnostics | 82% | |
| SD Biosensor Inc | 77% |
For institutional investors. Book with your work email.
Genomadix Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 29, 2022 | ||||
| Seed | Jul 21, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 6, 2.1x the trailing average.
- Jul 26, 2026
Monthly visitors grew 68% MoM.
For institutional investors. Book with your work email.
Genomadix Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomadix Inc.'s valuation, stock price, and market status.
Is Genomadix Inc. a public or private company?
Genomadix Inc. is a private company.
What is the current stock price of Genomadix Inc.?
Genomadix Inc. is a private company, so its shares have no public market price. Caplight tracks Genomadix Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomadix Inc. worth (valuation)?
Valuation information for Genomadix Inc. is not publicly available.
Can I buy Genomadix Inc. stock?
Genomadix Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomadix Inc.'s last funding round?
Genomadix Inc.'s most recent funding round was Strategic on August 29, 2022.
Who are the main investors in Genomadix Inc.?
Investor information for Genomadix Inc. is not publicly disclosed.
Will Genomadix Inc. IPO soon?
No public IPO plans have been announced for Genomadix Inc..
How can I track Genomadix Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Genomadix Inc.'s shares on secondary markets.